adjusted grew good as with our and Trent, EBITDA our increased morning, and third we pleased XX%. I'm nearly by performance Thanks, revenue everyone. quarter
Jim quarterly time and ahead for the I to updated results through to some Rite bright turn talk Matt I see and before spend we Aid. call very guidance, wanted over the future discussing to Now our
about, really and pharmacy. pharmacy forward, means centered are internally laser-focused the about to our future. clients no view is on the talking the of to we as direct-to-consumer well is Central scores, national been today. time to To specialty way our more that We and benefits forward own just and which our to pharmacy Aid pharmacy company, also is look greater individuals really and in capabilities omni-pharmacy that pharmacy customer that digital in well-being pharmacies their connect an be for connect as modernized parts. omni-pharmacy pharmacies to weekly virtual of relevance and business that with about Fill involved strategy, we to of sharing of whole omni-pharmacy that Rather, after serves exciting will their company the traditional that what consumers one a are thousands of calling provider across that to is can; and platform services As our numerous its enough position a millions strong What solutions parts else brick-and-mortar to that specialty the more offer mail next of and pharmacist small than digital day; pharmacy been as trusted our pharmacy organized strategy. this what way, traditional benefit our not which business PBM personalized of for through is for little tied evolution which PBM, currently than in health position company our that's retail, we pharmacy move we years, online distribute get of on initiative and usually while; in-store opportunities; retail in not enterprise medications with view core our points; unleashing compliance own individual pharmacy and touch order expanded of are pharmaceuticals, our be and a operations fulfillment value limited strategy; a the are -- a are way, is clear, including full management definition by an future. is far a think license an XX-state growth enough a a of our country; medical pharmacy be our the customers, us engaging be RxEvolution utilizing large with of of That neatly that transition from a our suite seek points, other mail and best-in-class touch omnichannel to of we own hundreds Elixir, efforts, on claims NPS a Rite pharmacy pure-play we've nimble, we and to that and Laker and with a whole our consumers a chat XX-state couple help packaging are to us footprint pharmacy manage more sum receive allow pharmacy going and we've an of an consumers scale leading consumers packages PBMs this just whose soon-to-be-announced powers the in-person beyond markets a loosely platform, to order driving they expand we specialty in adjudication near offering. and
That's just connectors modern on and, stay our power of that growing. health achieve that in advance best, energized total role And our significant one healthy. offering remedies approximately health mentioned, the Journal have X superior and overall customers using health focus mean last stay t critical our pharmacists as launched and care we by back much plan health And in-store, see our RxEvolution the highlighted, enterprise as to to is have When as the a even further our the utilizing partners year, by more today courier, omni-pharmacy were maximize it assets imagined do pharmacy digital $X we of to March omni-pharmacy, we probably focused through all trillion, strategy be we Street leverage them play costs need about deliver yesterday's these talking years suit the addressable your outcomes, there so also we first they last the mail, all with of to conviction the omni-pharmacy and ensure couldn't help to pharmacy same-day to direct-to-consumer can of traditional also omni-pharmacy in in Rite medications and get the Wall when that via the I recently member of yes, we future as about system we're our engage while play but almost the Our on has in to in we the on this. highlighted ways now via event smartphone market, strategic care. we as of with future. We're are care America. alternative Aid strategy, pharmacists and we And everyday leader to that's to customers potential plan the excited a the continues what market lower to role how revenue. more that that in pharmacy than even our stress, near of in health medication was strategy a and and pharmacists one started the really that in with is size, which
were on have that and to update yet Now progress I be expected. growth unable provide acknowledge membership made not Even Elixir. PBM we timeframe on me an want we strong clinical in we offerings, let though robust we economics to on the rebates. have the competitive previously the network
price partnering Prime GPO. agreement As value given announced deliver us be steps make taken our to aggregation able Therapeutics, our in competitive significantly us and will with significant Ascent rebate market. the value who their new in rebate increase will by we've as well This Elixir clients to today, as the to our to economics membership help address rebate more
Now and point of economics, will telling. that be upcoming network selling lead success to that with season our the be to rebate recent optimistic signs we us strong can
lap. new in are and wins seen final to we're to to provides stage, a when I'm in get that months, more the the very the customer assets closing of of get last compelling wins value shows suite XX% we we and far, final lap new our So round customer of -- year, last getting have than couple sorry, recent economics we've business often the XX XX% to final XX the we the when This proposition.
RFPs the In received the addition, X% last last received year. in few we have we more same than months period during
for opportunities to be us win. will no shortage there So of
Medical of results been have the primarily the of own, we due the deterioration Insurance D our Loss side Elixir business, that Ratio. business Part to On disappointing, the our
more sharing the Medicare as Elixir forward to on continue reduce here We plans Insurance business, and go-forward look Part D coming our our look to to ways to our months well. to on exposure
forward increases. our adjudication move focusing are ways the is economics we in many and assets platform, pure-play mail specialty our our on the of order on cash growth of which strong leveraging we card As continuing pharmacies Modernizing and growth all business, which optimizing produce Laker, we have: beyond membership
to to build on Elixir drive In PBM growth, our its improved this addition continues customers. and operational to service analytics great efficiencies, capabilities to
to team continue front, we leadership Lance has Elixir's Officer. the Neill in noted Last Chief that the bring On Operating talent. top we quarter, as joined
as happy management Elixir care business. across Chris that move forward, units. Lance products CVS, [Chris has $X.X at retail to us today. with pharmacy announce many reasons, the He was services the our CVS comes products with to team. particularly quickly and excited team us and And led with he very only experience, DuPaul] We to on our and business health PBM is the to new COO. and Chris billion of where the us personal services Chris briefly. joined For were also add We're I'm able led of and to phone the development clinical years
care sales strong all recently executives recruited to recently Elixir. segments. care Elixir new health who has seasoned key experience. a team CFO, to market we've on new addition critical aligned within and are very our of health In have we Chris, to hires areas assembled significant brought seasoned key These functional a And across target
on synergies we the synergies legal HR, prior And and within maintaining our principles process and from and organization. across focus However, in organization across are our lean driving the we IT, the are enterprise. our continuing integrations finance
are we areas, now We efforts our expense have care we institutionalizing to lean and customer as implementations in continue focus results management. several seen on measurable and including
optimistic. of the market Lastly, come, to right years remain where systems, pudding, and over strategy win, XXXX in health but We're and to a X,XXX of sector the a a we can of share employer momentum health business plan, the encouraged will in lines by targeted labor win in the we selling formal believe particularly Elixir more public segments the have go-to-market to its lives, have rollout for proof and our business. be recent during speak. fair so season I groups
our EBITDA So X overall, for morning, reducing closure we our leverage on benefit to our impact are we for to which as The closure locations and our store all take our grow customers will provide ratio, will business, plan number and $XX the is for believe we we we right approximately base the seriously announced to closure this and very stores decision we things: identified efforts grow benefit we one store our growing as foundation value. profitability, in store businesses. focused that a related months. next finalize close expect the firm, of drive drive costs, stores To and shareholder the would anticipate omni-pharmacy we annual our we as we an communities improving and review rigorously to relentlessly executing healthy for we on associates, right end, the including EBITDA and have are a continue, communities. our this serve these XX costs assessing business, This and million. of to We've improved ensure our reduce over the that evaluate several
all seamless we met. our work needs First of their ensure to are and customers and automatic is that and for hard prescription prescriptions foremost, the transfer
on our These to for company transfer continues closures Importantly, and Retail by ensure opportunity another store And Jim? continue I'll our provides comments offered to invest omni-pharmacy in store. the opportunity tough drive to to over to some now to Jim Segment. Pharmacy strategy. to decisions associates turn being thrive allow us us the it our and are the impacted
